Drug Therapy Safety Management

Drugs are an important part of therapy for many illnesses — but the more a patient needs, the more critical it becomes to ensure that the medicines work safely together. It is a task that demands specially qualified experts in a range of professional fields: physicians, pharmacists, and nursing staff with advanced qualifications in the field of drug therapy safety management are on the front lines in preventing unnecessary side effects and interactions, hospitalizations, or life-threatening situations. Alongside expertise in drug interactions, cooperation across various professional fields is required to identify and assess risk situations, and navigate the prescription process as safely as possible.

The master’s degree for continuing education in Drug Therapy Safety Management is offered by the University of Bonn in association with Heidelberg University and the University of Tübingen. Additional project partners providing drug therapy safety management expertise for this degree program include the Federal Institute for Drugs and Medical Devices (BfArM) and the Institute of Patient Safety in the Faculty of Medicine. This cross-disciplinary degree program is especially, but not exclusively, oriented toward university graduates in the fields of medicine, pharmacy, and nursing who have already gathered at least one year of relevant professional experience and who wish to expand their qualifications in a scientifically sound manner.

Possible Lines of Work:

AMTS experts in care facilities, hospitals, pharmacies, physicians’ practices, health insurance companies, and oversight agencies

Tuition: €9,900 total

Master’s degree programs for continuing education are subject to tuition. The amount of tuition depends on the range of courses offered in the particular degree program and is based the program’s scale of charges.